On Friday the 29th of November, we participated in the workshop “State-of-the-art: Telemonitoring the allergic patient”, for the research program that our team provides its tech expertise in, the Personal Allergy Tracer (P.A.T.), during the Conference “New Perspectives on Allergology”, organized in Kastoria, Greece, from 29/11 to 1/12.
Furthermore, we had an internal project meeting with the Consortium, Vidavo S.A, the University of Athens, Allergology / Special Account for Research Funds, the University of Patras / Special Account for Research Funds and the Athena Research & Innovation Information Technologies Institute, to discuss about the progress of the project and make some decisions, focusing on the data collection process, the development of kinesiology and sound algorithms, the implementation of the mobile application and the forthcoming pilot phase
Last but not least, we attended an internal technical meeting on all open issues that we are dealing with on a technical level regarding P.A.T.’s development.
Α few words about Personal Allergy Tracer (P.A.T.)
P.A.T. aims to create an integrated, crowdsourcing e-Health / m-Health system for the continuous monitoring of individual patient’s health status and the intelligent detection of the outbreak of their allergic illness, the frequent electronic notification of the assigned physician and finally the extraction of statistics with respect to the various forms of seasonal allergies and the individuals who are affected by them.
The project will deliver a research prototype for the automated monitoring of patients with respiratory allergy and the development of notification services for these patients, based on kinetic and acoustic characteristics, collected from wearables and mobile devices. The crowdsourced information, collected both from sensors and other smart devices and the patient’s self-assessment, will be exploited by health professionals to better control and manage seasonal symptoms in allergic diseases in support to decision making in the allergy related medical sector.
The automated process for recording signs and symptoms of the respiratory allergy, in conjunction with the automated notification services, will decisively contribute to the control of the allergic respiratory diseases, by reducing morbidity and improving the quality of patients’ life and their performance. It will also have a positive economic impact by reducing the loss of working hours and maintaining the productivity of patients with respiratory allergy.